Netherlands, Utrecht

Pharmaceutical Policy Analysis

when 13 July 2020 - 17 July 2020
language English
duration 1 week
credits 1.5 EC
fee EUR 975

This course will give students insight into current developments in pharmaceutical policy making and a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide lecturers for several of the sessions. You will experience an intensive programme covering the following topics: pharmaceutical policy analysis issues and methods; availability and affordability of medicines; universal health coverage; pricing and reimbursement (including the role of health technology assessment); regulatory issues and challenges; policy and politics; synthesis, case studies & public health.

Medicines are among the most regelated products in society. From the earliest pre-clinical stages onward, policy makers want to foster the development of safe, effective and affordable medicines for patients in need of pharmacotherapy. When a drug reaches the market, it is the beginning of a process of complex interactions between patients, prescribers, insurers, pharmaceutical companies and governments. Furthermore, the inequity in access to medicines is still a defining characteristic of the global pharmaceutical market place. The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions.

As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions. You will experience an intensive programme covering the following topics: pharmaceutical policy analysis issues and methods; availability and affordability of medicines; universal health coverage; pricing and reimbursement (including the role of health technology assessment); regulatory issues and challenges; policy and politics; synthesis, case studies & public health.

Course leader

Prof. Dr. Aukje Mantel-Teeuwisse

Target group

(Post)graduates and professionals within governments, NGOs, industry, universities with a basic knowledge of public health/medicine, who have an interest in the policy aspects of pharmaceuticals and/or pharmacoepidemiology.

Course aim

The aim of the course is to give students insight into current developments in pharmaceutical policy making as well to give a better understanding of the methods available for analysing the effects of policy interventions. As a collaborator on this course, the World Health Organization will provide faculty for several of the sessions.

Fee info

EUR 975: Course + course materials + lunch
EUR 200: Housing fee (optional)

Register for this course
on course website